Test Bank For Pathophysiology 7th Edition by
b b b b b b b
b Jacquelyn L. Banasik Chapter 1-54-Grades A+-2023-
b b b b b
2024 b
Chapter b01: bIntroduction bto bPathophysiology
bBanasik: bPathophysiology, b7th bEdition
MULTIPLE bCHOICE
1. C.Q. bwas brecently bexposed bto bgroup bA bhemolytic bStreptococcus band bsubsequently
developed ba bpharyngeal binfection. bHis bclinic bexamination breveals ban boral btemperature bof
b
102.3°F, bskin brash, bdysphagia, band breddened bthroat bmucosa bwith bmultiple bpustules. bHe
b
bcomplains bof bsore bthroat, bmalaise, band bjoint bstiffness. bA bthroat bculture bis bpositive bfor
bStreptococcus, band bantibiotics bhave bbeen bprescribed. bThe betiology bof bC.Q.’s bdisease bis
a. a bsore bthroat.
b. streptococcal binfection.
c. genetic bsusceptibility.
d. pharyngitis.
ANS: b B
Etiology brefers bto bthe bproposed bcause bor bcauses bof ba bparticular bdisease bprocess. bA bsore
bthroat bis bthe bmanifestation bof bthe bdisease bprocess. bGenetic bsusceptibility brefers bto binherited
btendency bto bdevelop ba bdisease. bPharyngitis brefers bto binflammation bof bthe bthroat band bis
balso ba bclinical bmanifestation bof bthe bdisease bprocess.
2. A b17-year-old bcollege-bound bstudent breceives ba bvaccine bagainst ban borganism bthat
causes bmeningitis. bThis bis ban bexample bof
b
a. primary bprevention.
b. secondary bprevention.
c. tertiary bprevention.
d. disease btreatment.
ANS: b A
Primary bprevention bis bprevention bof bdisease bby baltering bsusceptibility bor breducing bexposure
bfor bsusceptible bindividuals, bin bthis bcase bby bproviding bvaccination. bSecondary bprevention bis
bthe bearly bdetection, bscreening, band bmanagement bof bthe bdisease. bTertiary bprevention
bincludes brehabilitative band bsupportive bcare band battempts bto balleviate bdisability band brestore
beffective bfunctioning. bDisease btreatment binvolves bmanagement bof bthe bdisease bonce bit bhas
bdeveloped.
3. An bobese bbut botherwise bhealthy bteen bis bgiven ba bprescription bfor ba blow-calorie bdiet band
exercise bprogram. bThis bis ban bexample bof
b
a. primary bprevention.
b. secondary bprevention.
c. tertiary bprevention.
d. disease btreatment.
ANS: b B
Secondary bprevention bis bthe bearly bdetection, bscreening, band bmanagement bof bthe bdisease bsuch
bas bprescribing bdiet band bexercise bfor ban bindividual bwho bhas balready bdeveloped bobesity.
bPrimary bprevention bis bprevention bof bdisease bby baltering bsusceptibility bor breducing
bexposure bfor bsusceptible bindividuals. bTertiary bprevention bincludes brehabilitative band
bsupportive bcare band battempts bto balleviate bdisability band brestore beffective bfunctioning.
bDisease btreatment binvolves bmanagement bof bthe bdisease bonce bit bhas bdeveloped.
,4. A bpatient bwith bhigh bblood bpressure bwho bis botherwise bhealthy bis bcounseled bto brestrict
sodium bintake. bThis bis ban bexample bof
b
a. primary bprevention.
b. secondary bprevention.
c. tertiary bprevention.
d. disease btreatment.
ANS: b B
Secondary bprevention bis bthe bearly bdetection, bscreening, band bmanagement bof bthe bdisease,
bsuch bas bby bprescribing bsodium brestriction bfor bhigh bblood bpressure. bPrimary bprevention bis
bprevention bof bdisease bby baltering bsusceptibility bor breducing bexposure bfor bsusceptible
bindividuals. bTertiary bprevention bincludes brehabilitative band bsupportive bcare band battempts
bto balleviate bdisability band brestore beffective bfunctioning. bDisease btreatment binvolves
bmanagement bof bthe bdisease bonce bit bhas bdeveloped.
5. After bsuffering ba bheart battack, ba bmiddle-aged bman bis bcounseled bto btake ba bcholesterol-
lowering bmedication. bThis bis ban bexample bof
a. primary bprevention.
b. secondary bprevention.
c. tertiary bprevention.
d. disease btreatment.
ANS: b C
Tertiary bprevention bincludes brehabilitative band bsupportive bcare band battempts bto balleviate
bdisability band brestore beffective bfunctioning bsuch bas bprescribing ba bcholesterol-lowering
bmedication bfollowing ba bheart battack. bPrimary bprevention bis bprevention bof bdisease bby
baltering bsusceptibility bor breducing bexposure bfor bsusceptible bindividuals. bSecondary
bprevention bis bthe bearly bdetection, bscreening, band bmanagement bof bthe bdisease. bDisease
btreatment binvolves bmanagement bof bthe bdisease bonce bit bhas bdeveloped.
6. A bpatient bhas bbeen bexposed bto bmeningococcal bmeningitis, bbut bis bnot byet bdemonstrating
signs bof bthis bdisease. bThis bstage bof billness bis bcalled bthe stage.
b
a. prodromal
b. latent
c. sequela
d. convalescence
ANS: b B
Incubation brefers bto bthe binterval bbetween bexposure bof ba btissue bto ban binjurious bagent band bthe
bfirst bappearance bof bsigns band bsymptoms. bIn binfectious bdiseases, bthis bperiod bis boften bcalled
bthe bincubation b(latent) bperiod. bProdromal brefers bto bthe bappearance bof bthe bfirst bsigns band
bsymptoms bindicating bthe bonset bof ba bdisease. bThese bare boften bnonspecific, bsuch bas
bheadache, bmalaise, banorexia, band bnausea, bwhich bare bassociated bwith ba bnumber bof bdifferent
bdiseases. bSequela brefers bto bsubsequent bpathologic bcondition bresulting bfrom ba bdisease.
bConvalescence bis bthe bstage bof brecovery bafter ba bdisease, binjury, bor bsurgical boperation.
7. A bdisease bthat bis bnative bto ba bparticular bregion bis bcalled
a. epidemic.
b. endemic.
c. pandemic.
d. ethnographic.
, ANS: b B
A bdisease bthat bis bnative bto ba bparticular bregion bis bcalled bendemic. bAn bepidemic bis ba bdisease
bthat bspreads bto bmany bindividuals bat bthe bsame btime. bPandemics bare bepidemics bthat baffect
blarge bgeographic bregions, bperhaps bspreading bworldwide. bEthnographic bdoes bnot bdescribe ba
bdisease bdistribution bpattern.
8. In bgeneral, bwith baging, borgan bsize band bfunction
a. increase.
b. decrease.
c. remain bthe bsame.
d. are bunknown.
ANS: b B
In bgeneral, bwith baging, borgan bsize band bfunction bdecrease.
9. The bstage bduring bwhich bthe bpatient bfunctions bnormally, balthough bthe bdisease bprocesses bare
well bestablished, bis breferred bto bas
b
a. latent.
b. subclinical.
c. prodromal.
d. convalescence.
ANS: b B
The bstage bduring bwhich bthe bpatient bfunctions bnormally, balthough bthe bdisease bprocesses bare
bwell bestablished, bis bcalled bthe bsubclinical bstage. bThe binterval bbetween bexposure bof ba btissue
bto ban binjurious bagent band bthe bfirst bappearance bof bsigns band bsymptoms bmay bbe bcalled ba
blatent bperiod bor, bin bthe bcase bof binfectious bdiseases, ban bincubation bperiod. bThe bprodromal
bperiod, bor bprodrome, brefers bto bthe bappearance bof bthe bfirst bsigns band bsymptoms bindicating
bthe bonset bof ba bdisease. bConvalescence bis bthe bstage bof brecovery bafter ba bdisease, binjury, bor
bsurgical boperation.
MULTIPLE bRESPONSE
1. Your bpatient’s bred bblood bcell bcount bis bslightly belevated btoday. bThis bmight bbe bexplained
by b(Select ball bthat bapply.)
b
a. gender bdifference.
b. situational bfactors.
c. normal bvariation.
d. cultural bvariation.
e. illness.
ANS: b A, bB, bC, bE
Gender, bsituations b(e.g., baltitude), bnormal bvariations, band billness bmay ball bdetermine bred
bblood bcell bcount. bCulture baffects bhow bmanifestations bare bperceived b(normal bversus
babnormal).
2. Socioeconomic bfactors binfluence bdisease bdevelopment bbecause bof b(Select ball bthat bapply.)
a. genetics.
b. environmental btoxins.
c. overcrowding.
d. nutrition.
e. hygiene.
, ANS: b B, bC, bD, bE
Socioeconomic bfactors binfluence bdisease bdevelopment bvia bexposure bto benvironmental btoxins
b(occupational) band bovercrowding, bnutrition b(over- bor bundernutrition), band bhygiene b(e.g., bin
bdeveloping bcountries). bGenetics bis bnot binfluenced bby bsocioeconomic bfactors.
3. When bdetermining badditional bdata bto bgather bbefore bmaking ba bdiagnosis, bwhat bfactors
need bto bbe bconsidered? b(Select ball bthat bapply.)
b
a. Reliability
b. Expense
c. Validity
d. Generalizability
e. Repetition
ANS: b A, bC
Two bconsiderations bone bmust buse bwhen bchoosing badditional bdata bto bgather binclude bthe
breliability band bvalidity bof bthe btests bbeing bweighed. bReliability, bor bprecision, bis bthe bability
bof ba btest bto bgive bthe bsame bresult bin brepeated bmeasurements. bValidity, bor baccuracy, bis bthe
bdegree bto bwhich ba bmeasurement breflects bthe btrue bvalue bof bthe bobject bit bis bintended bto
bmeasure. bExpense, bgeneralizability, band brepetition bare bnot bcharacteristics bthat bare btypically
bconsidered.
4. Which bof bthe bfollowing bstatements bare baccurate bwhen bconsidering bdiagnostic btesting bfor
an bindividual bwith ba bpossible bmedical bcondition? b(Select ball bthat bapply.)
b
a. The bmore boften ba bpatient bhas ba btest, bthe bmore baccurate bthe baverage bresult bis.
b. Sensitivity bis bthe bchance bthe btest bwill bbe bpositive bif bthe bhypothesized
disease bis bpresent.
b
c. Testing bis bgenerally bnot baccurate bduring bthe bprodromal bstage bto bmake ba bdiagnosis.
d. Specificity bshows bthat ba btest bwill bbe bnegative bif bthe bperson bdoes bnot bhave
the bdisease.
b
e. Reliability bdemonstrates ba btest bis baccurate bunder ba bnumber bof bdifferent bconditions.
ANS: b B, bD
Sensitivity bis bthe bprobability bthat bthe btest bwill bbe bpositive bwhen bapplied bto ba bperson bwith
bthe bcondition. bSpecificity bis bthe bprobability bthat ba btest bwill bbe bnegative bwhen bapplied bto ba
bperson bwho bdoes bnot bhave ba bgiven bcondition. bTest bresults bare busually bnot baggregated band
baveraged. bA bdisease bprocess bis bwell bestablished bduring bthe bprodromal bphase bof billness, bso
bsome bdiagnostic btesting bwould bindicate bits bpresence. bReliability, bor bprecision, bis bthe bability
bof ba btest bto bgive bthe bsame bresult bin brepeated bmeasurements.
Chapter b02: bHomeostasis, bAllostasis, band bAdaptive bResponses bto bStressors
bBanasik: bPathophysiology, b7th bEdition
MULTIPLE bCHOICE
1. Indicators bthat ban bindividual bis bexperiencing bhigh bstress binclude ball bthe bfollowing bexcept
a. tachycardia.
b. diaphoresis.
c. increased bperipheral bresistance.
d. pupil bconstriction.
ANS: b D
b b b b b b b
b Jacquelyn L. Banasik Chapter 1-54-Grades A+-2023-
b b b b b
2024 b
Chapter b01: bIntroduction bto bPathophysiology
bBanasik: bPathophysiology, b7th bEdition
MULTIPLE bCHOICE
1. C.Q. bwas brecently bexposed bto bgroup bA bhemolytic bStreptococcus band bsubsequently
developed ba bpharyngeal binfection. bHis bclinic bexamination breveals ban boral btemperature bof
b
102.3°F, bskin brash, bdysphagia, band breddened bthroat bmucosa bwith bmultiple bpustules. bHe
b
bcomplains bof bsore bthroat, bmalaise, band bjoint bstiffness. bA bthroat bculture bis bpositive bfor
bStreptococcus, band bantibiotics bhave bbeen bprescribed. bThe betiology bof bC.Q.’s bdisease bis
a. a bsore bthroat.
b. streptococcal binfection.
c. genetic bsusceptibility.
d. pharyngitis.
ANS: b B
Etiology brefers bto bthe bproposed bcause bor bcauses bof ba bparticular bdisease bprocess. bA bsore
bthroat bis bthe bmanifestation bof bthe bdisease bprocess. bGenetic bsusceptibility brefers bto binherited
btendency bto bdevelop ba bdisease. bPharyngitis brefers bto binflammation bof bthe bthroat band bis
balso ba bclinical bmanifestation bof bthe bdisease bprocess.
2. A b17-year-old bcollege-bound bstudent breceives ba bvaccine bagainst ban borganism bthat
causes bmeningitis. bThis bis ban bexample bof
b
a. primary bprevention.
b. secondary bprevention.
c. tertiary bprevention.
d. disease btreatment.
ANS: b A
Primary bprevention bis bprevention bof bdisease bby baltering bsusceptibility bor breducing bexposure
bfor bsusceptible bindividuals, bin bthis bcase bby bproviding bvaccination. bSecondary bprevention bis
bthe bearly bdetection, bscreening, band bmanagement bof bthe bdisease. bTertiary bprevention
bincludes brehabilitative band bsupportive bcare band battempts bto balleviate bdisability band brestore
beffective bfunctioning. bDisease btreatment binvolves bmanagement bof bthe bdisease bonce bit bhas
bdeveloped.
3. An bobese bbut botherwise bhealthy bteen bis bgiven ba bprescription bfor ba blow-calorie bdiet band
exercise bprogram. bThis bis ban bexample bof
b
a. primary bprevention.
b. secondary bprevention.
c. tertiary bprevention.
d. disease btreatment.
ANS: b B
Secondary bprevention bis bthe bearly bdetection, bscreening, band bmanagement bof bthe bdisease bsuch
bas bprescribing bdiet band bexercise bfor ban bindividual bwho bhas balready bdeveloped bobesity.
bPrimary bprevention bis bprevention bof bdisease bby baltering bsusceptibility bor breducing
bexposure bfor bsusceptible bindividuals. bTertiary bprevention bincludes brehabilitative band
bsupportive bcare band battempts bto balleviate bdisability band brestore beffective bfunctioning.
bDisease btreatment binvolves bmanagement bof bthe bdisease bonce bit bhas bdeveloped.
,4. A bpatient bwith bhigh bblood bpressure bwho bis botherwise bhealthy bis bcounseled bto brestrict
sodium bintake. bThis bis ban bexample bof
b
a. primary bprevention.
b. secondary bprevention.
c. tertiary bprevention.
d. disease btreatment.
ANS: b B
Secondary bprevention bis bthe bearly bdetection, bscreening, band bmanagement bof bthe bdisease,
bsuch bas bby bprescribing bsodium brestriction bfor bhigh bblood bpressure. bPrimary bprevention bis
bprevention bof bdisease bby baltering bsusceptibility bor breducing bexposure bfor bsusceptible
bindividuals. bTertiary bprevention bincludes brehabilitative band bsupportive bcare band battempts
bto balleviate bdisability band brestore beffective bfunctioning. bDisease btreatment binvolves
bmanagement bof bthe bdisease bonce bit bhas bdeveloped.
5. After bsuffering ba bheart battack, ba bmiddle-aged bman bis bcounseled bto btake ba bcholesterol-
lowering bmedication. bThis bis ban bexample bof
a. primary bprevention.
b. secondary bprevention.
c. tertiary bprevention.
d. disease btreatment.
ANS: b C
Tertiary bprevention bincludes brehabilitative band bsupportive bcare band battempts bto balleviate
bdisability band brestore beffective bfunctioning bsuch bas bprescribing ba bcholesterol-lowering
bmedication bfollowing ba bheart battack. bPrimary bprevention bis bprevention bof bdisease bby
baltering bsusceptibility bor breducing bexposure bfor bsusceptible bindividuals. bSecondary
bprevention bis bthe bearly bdetection, bscreening, band bmanagement bof bthe bdisease. bDisease
btreatment binvolves bmanagement bof bthe bdisease bonce bit bhas bdeveloped.
6. A bpatient bhas bbeen bexposed bto bmeningococcal bmeningitis, bbut bis bnot byet bdemonstrating
signs bof bthis bdisease. bThis bstage bof billness bis bcalled bthe stage.
b
a. prodromal
b. latent
c. sequela
d. convalescence
ANS: b B
Incubation brefers bto bthe binterval bbetween bexposure bof ba btissue bto ban binjurious bagent band bthe
bfirst bappearance bof bsigns band bsymptoms. bIn binfectious bdiseases, bthis bperiod bis boften bcalled
bthe bincubation b(latent) bperiod. bProdromal brefers bto bthe bappearance bof bthe bfirst bsigns band
bsymptoms bindicating bthe bonset bof ba bdisease. bThese bare boften bnonspecific, bsuch bas
bheadache, bmalaise, banorexia, band bnausea, bwhich bare bassociated bwith ba bnumber bof bdifferent
bdiseases. bSequela brefers bto bsubsequent bpathologic bcondition bresulting bfrom ba bdisease.
bConvalescence bis bthe bstage bof brecovery bafter ba bdisease, binjury, bor bsurgical boperation.
7. A bdisease bthat bis bnative bto ba bparticular bregion bis bcalled
a. epidemic.
b. endemic.
c. pandemic.
d. ethnographic.
, ANS: b B
A bdisease bthat bis bnative bto ba bparticular bregion bis bcalled bendemic. bAn bepidemic bis ba bdisease
bthat bspreads bto bmany bindividuals bat bthe bsame btime. bPandemics bare bepidemics bthat baffect
blarge bgeographic bregions, bperhaps bspreading bworldwide. bEthnographic bdoes bnot bdescribe ba
bdisease bdistribution bpattern.
8. In bgeneral, bwith baging, borgan bsize band bfunction
a. increase.
b. decrease.
c. remain bthe bsame.
d. are bunknown.
ANS: b B
In bgeneral, bwith baging, borgan bsize band bfunction bdecrease.
9. The bstage bduring bwhich bthe bpatient bfunctions bnormally, balthough bthe bdisease bprocesses bare
well bestablished, bis breferred bto bas
b
a. latent.
b. subclinical.
c. prodromal.
d. convalescence.
ANS: b B
The bstage bduring bwhich bthe bpatient bfunctions bnormally, balthough bthe bdisease bprocesses bare
bwell bestablished, bis bcalled bthe bsubclinical bstage. bThe binterval bbetween bexposure bof ba btissue
bto ban binjurious bagent band bthe bfirst bappearance bof bsigns band bsymptoms bmay bbe bcalled ba
blatent bperiod bor, bin bthe bcase bof binfectious bdiseases, ban bincubation bperiod. bThe bprodromal
bperiod, bor bprodrome, brefers bto bthe bappearance bof bthe bfirst bsigns band bsymptoms bindicating
bthe bonset bof ba bdisease. bConvalescence bis bthe bstage bof brecovery bafter ba bdisease, binjury, bor
bsurgical boperation.
MULTIPLE bRESPONSE
1. Your bpatient’s bred bblood bcell bcount bis bslightly belevated btoday. bThis bmight bbe bexplained
by b(Select ball bthat bapply.)
b
a. gender bdifference.
b. situational bfactors.
c. normal bvariation.
d. cultural bvariation.
e. illness.
ANS: b A, bB, bC, bE
Gender, bsituations b(e.g., baltitude), bnormal bvariations, band billness bmay ball bdetermine bred
bblood bcell bcount. bCulture baffects bhow bmanifestations bare bperceived b(normal bversus
babnormal).
2. Socioeconomic bfactors binfluence bdisease bdevelopment bbecause bof b(Select ball bthat bapply.)
a. genetics.
b. environmental btoxins.
c. overcrowding.
d. nutrition.
e. hygiene.
, ANS: b B, bC, bD, bE
Socioeconomic bfactors binfluence bdisease bdevelopment bvia bexposure bto benvironmental btoxins
b(occupational) band bovercrowding, bnutrition b(over- bor bundernutrition), band bhygiene b(e.g., bin
bdeveloping bcountries). bGenetics bis bnot binfluenced bby bsocioeconomic bfactors.
3. When bdetermining badditional bdata bto bgather bbefore bmaking ba bdiagnosis, bwhat bfactors
need bto bbe bconsidered? b(Select ball bthat bapply.)
b
a. Reliability
b. Expense
c. Validity
d. Generalizability
e. Repetition
ANS: b A, bC
Two bconsiderations bone bmust buse bwhen bchoosing badditional bdata bto bgather binclude bthe
breliability band bvalidity bof bthe btests bbeing bweighed. bReliability, bor bprecision, bis bthe bability
bof ba btest bto bgive bthe bsame bresult bin brepeated bmeasurements. bValidity, bor baccuracy, bis bthe
bdegree bto bwhich ba bmeasurement breflects bthe btrue bvalue bof bthe bobject bit bis bintended bto
bmeasure. bExpense, bgeneralizability, band brepetition bare bnot bcharacteristics bthat bare btypically
bconsidered.
4. Which bof bthe bfollowing bstatements bare baccurate bwhen bconsidering bdiagnostic btesting bfor
an bindividual bwith ba bpossible bmedical bcondition? b(Select ball bthat bapply.)
b
a. The bmore boften ba bpatient bhas ba btest, bthe bmore baccurate bthe baverage bresult bis.
b. Sensitivity bis bthe bchance bthe btest bwill bbe bpositive bif bthe bhypothesized
disease bis bpresent.
b
c. Testing bis bgenerally bnot baccurate bduring bthe bprodromal bstage bto bmake ba bdiagnosis.
d. Specificity bshows bthat ba btest bwill bbe bnegative bif bthe bperson bdoes bnot bhave
the bdisease.
b
e. Reliability bdemonstrates ba btest bis baccurate bunder ba bnumber bof bdifferent bconditions.
ANS: b B, bD
Sensitivity bis bthe bprobability bthat bthe btest bwill bbe bpositive bwhen bapplied bto ba bperson bwith
bthe bcondition. bSpecificity bis bthe bprobability bthat ba btest bwill bbe bnegative bwhen bapplied bto ba
bperson bwho bdoes bnot bhave ba bgiven bcondition. bTest bresults bare busually bnot baggregated band
baveraged. bA bdisease bprocess bis bwell bestablished bduring bthe bprodromal bphase bof billness, bso
bsome bdiagnostic btesting bwould bindicate bits bpresence. bReliability, bor bprecision, bis bthe bability
bof ba btest bto bgive bthe bsame bresult bin brepeated bmeasurements.
Chapter b02: bHomeostasis, bAllostasis, band bAdaptive bResponses bto bStressors
bBanasik: bPathophysiology, b7th bEdition
MULTIPLE bCHOICE
1. Indicators bthat ban bindividual bis bexperiencing bhigh bstress binclude ball bthe bfollowing bexcept
a. tachycardia.
b. diaphoresis.
c. increased bperipheral bresistance.
d. pupil bconstriction.
ANS: b D
